Inactive Instrument

Boule Diagnostics AB Stock price Nasdaq Stockholm

Equities

SE0000437402

Advanced Medical Equipment & Technology

Sales 2023 571M 53.49M Sales 2024 * 580M 54.28M Capitalization 386M 36.1M
Net income 2023 25M 2.34M Net income 2024 * 31M 2.9M EV / Sales 2023 0.87 x
Net Debt 2023 60.2M 5.64M Net Debt 2024 * 72.84M 6.82M EV / Sales 2024 * 0.79 x
P/E ratio 2023
17.5 x
P/E ratio 2024 *
12.3 x
Employees -
Yield 2023 *
1.96%
Yield 2024 *
2.06%
Free-Float 61.67%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 58 20-05-10
Director of Finance/CFO - Dec. 31
Sales & Marketing - 21-09-30
Members of the board TitleAgeSince
Director/Board Member 63 15-12-31
Chairman 71 20-12-31
Director/Board Member 72 20-12-31
More insiders
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company's product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company's primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Calendar
More about the company
  1. Stock
  2. Equities
  3. Stock Boule Diagnostics AB
  4. Stock Boule Diagnostics AB - Nasdaq Stockholm